These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11553978)

  • 1. Magnetic resonance imaging and spectroscopy in Parkinson's disease.
    Martin WR
    Adv Neurol; 2001; 86():197-203. PubMed ID: 11553978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential of advanced MR imaging techniques in the differential diagnosis of parkinsonism.
    Hotter A; Esterhammer R; Schocke MF; Seppi K
    Mov Disord; 2009; 24 Suppl 2():S711-20. PubMed ID: 19877241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease.
    Geng DY; Li YX; Zee CS
    Neurosurgery; 2006 Feb; 58(2):256-62; discussion 256-62. PubMed ID: 16462479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: an in vivo MR study.
    Zhang J; Zhang Y; Wang J; Cai P; Luo C; Qian Z; Dai Y; Feng H
    Brain Res; 2010 May; 1330():124-30. PubMed ID: 20303339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance relaxometry in Parkinson's disease.
    Mondino F; Filippi P; Magliola U; Duca S
    Neurol Sci; 2002 Sep; 23 Suppl 2():S87-8. PubMed ID: 12548357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts.
    Michaeli S; Oz G; Sorce DJ; Garwood M; Ugurbil K; Majestic S; Tuite P
    Mov Disord; 2007 Feb; 22(3):334-40. PubMed ID: 17149719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain magnetic resonance imaging techniques in the diagnosis of parkinsonian syndromes.
    Seppi K; Poewe W
    Neuroimaging Clin N Am; 2010 Feb; 20(1):29-55. PubMed ID: 19959017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative estimation of regional brain iron with magnetic resonance imaging.
    Martin WR
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S215-8. PubMed ID: 20082994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased intracranial volume in Parkinson's disease.
    Krabbe K; Karlsborg M; Hansen A; Werdelin L; Mehlsen J; Larsson HB; Paulson OB
    J Neurol Sci; 2005 Dec; 239(1):45-52. PubMed ID: 16225890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease.
    O'Neill J; Schuff N; Marks WJ; Feiwell R; Aminoff MJ; Weiner MW
    Mov Disord; 2002 Sep; 17(5):917-27. PubMed ID: 12360540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal ganglia iron content in Parkinson's disease measured with magnetic resonance.
    Ye FQ; Allen PS; Martin WR
    Mov Disord; 1996 May; 11(3):243-9. PubMed ID: 8723139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midbrain iron content in early Parkinson disease: a potential biomarker of disease status.
    Martin WR; Wieler M; Gee M
    Neurology; 2008 Apr; 70(16 Pt 2):1411-7. PubMed ID: 18172063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of high-field MRI for studies in Parkinson's disease.
    Schuff N
    Mov Disord; 2009; 24 Suppl 2():S684-90. PubMed ID: 19877239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance spectroscopy in Parkinson's disease and parkinsonian syndromes.
    Rango M; Arighi A; Biondetti P; Barberis B; Bonifati C; Blandini F; Pacchetti C; Martignoni E; Bresolin N; Nappi G
    Funct Neurol; 2007; 22(2):75-9. PubMed ID: 17637209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of MRI in diagnosis and differential diagnosis of Parkinson's disease.
    Mahlknecht P; Hotter A; Hussl A; Esterhammer R; Schocke M; Seppi K
    Neurodegener Dis; 2010; 7(5):300-18. PubMed ID: 20616565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI assessment of basal ganglia iron deposition in Parkinson's disease.
    Wallis LI; Paley MN; Graham JM; Grünewald RA; Wignall EL; Joy HM; Griffiths PD
    J Magn Reson Imaging; 2008 Nov; 28(5):1061-7. PubMed ID: 18972346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging in parkinsonism.
    Olanow CW
    Neurol Clin; 1992 May; 10(2):405-20. PubMed ID: 1584182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores.
    Atasoy HT; Nuyan O; Tunc T; Yorubulut M; Unal AE; Inan LE
    Neurol India; 2004 Sep; 52(3):332-7. PubMed ID: 15472421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease.
    Schocke MF; Seppi K; Esterhammer R; Kremser C; Mair KJ; Czermak BV; Jaschke W; Poewe W; Wenning GK
    Neuroimage; 2004 Apr; 21(4):1443-51. PubMed ID: 15050569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural changes in the midbrain with aging and Parkinson's disease: an MRI study.
    Sohmiya M; Tanaka M; Aihara Y; Okamoto K
    Neurobiol Aging; 2004 Apr; 25(4):449-53. PubMed ID: 15013565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.